Sheba Medical Center
| Israel | Turkey | Austria | |
| Chemotherapy | from $620 | from $3,000 | from $2,500 |
| Bone marrow transplantation | from $255,000 | from $27,500 | from $140,000 |
| Allogenic bone marrow transplantation from an unrelated donor | from $150,000 | from $66,000 | from $180,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Chemotherapy for breast cancer | - | from $1,200 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Burkitt"s lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Burkitt"s lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Burkitt"s lymphoma treatment journey.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.